Chalice Brands Ltd (CHALF)
0.00
USD |
OTCM |
May 14, 16:00
Chalice Brands Shareholders Equity (Quarterly): 16.43M for Sept. 30, 2021
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2021 | 16.43M |
| June 30, 2021 | 15.65M |
| March 31, 2021 | 12.80M |
| December 31, 2020 | 5.472M |
| September 30, 2020 | 3.210M |
| June 30, 2020 | 5.593M |
| March 31, 2020 | 8.400M |
| December 31, 2019 | 10.60M |
| September 30, 2019 | 46.53M |
| June 30, 2019 | 39.63M |
| March 31, 2019 | 43.06M |
| December 31, 2018 | 46.59M |
| September 30, 2018 | 54.43M |
| June 30, 2018 | 59.16M |
| Date | Value |
|---|---|
| March 31, 2018 | 53.28M |
| December 31, 2017 | 17.34M |
| September 30, 2017 | 47.45M |
| June 30, 2017 | 6.461M |
| March 31, 2017 | 2.589M |
| December 31, 2016 | -2.936M |
| September 30, 2016 | 8.070M |
| June 30, 2016 | 9.820M |
| March 31, 2016 | 10.79M |
| June 30, 2015 | -0.0389M |
| March 31, 2015 | -0.027M |
| December 31, 2014 | 0.0025M |
| March 31, 2014 | 0.0121M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.210M
Minimum
Sep 2020
46.53M
Maximum
Sep 2019
16.43M
Average
11.70M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.37M |
| Total Liabilities (Quarterly) | 27.58M |